Kong, D., Lee, J., Kim, J. H., Kim, S. T., Kim, W. S., Suh, Y., . . . Nam, D. (2010). Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Oxford University Press.
Παραπομπή Chicago StyleKong, Doo-Sik, Jung-Il Lee, Jong Hyun Kim, Sung Tae Kim, Won Seog Kim, Yeon-Lim Suh, Seung Myung Dong, και Do-Hyun Nam. Phase II Trial of Low-dose Continuous (metronomic) Treatment of Temozolomide for Recurrent Glioblastoma. Oxford University Press, 2010.
Παραπομπή MLAKong, Doo-Sik, et al. Phase II Trial of Low-dose Continuous (metronomic) Treatment of Temozolomide for Recurrent Glioblastoma. Oxford University Press, 2010.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.